Insulet Corp (PODD)
174.43
+1.01
(+0.58%)
USD |
NASDAQ |
May 03, 16:00
174.46
+0.03
(+0.02%)
After-Hours: 20:00
Insulet Cash from Investing (Quarterly): -31.60M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.60M |
| September 30, 2023 | -22.60M |
| June 30, 2023 | -23.10M |
| March 31, 2023 | -42.10M |
| December 31, 2022 | -88.40M |
| September 30, 2022 | -33.90M |
| June 30, 2022 | -21.90M |
| March 31, 2022 | -46.90M |
| December 31, 2021 | -36.40M |
| September 30, 2021 | -12.20M |
| June 30, 2021 | -11.40M |
| March 31, 2021 | -22.70M |
| December 31, 2020 | -69.30M |
| September 30, 2020 | 2.70M |
| June 30, 2020 | 67.20M |
| March 31, 2020 | 13.40M |
| December 31, 2019 | -54.00M |
| September 30, 2019 | 12.20M |
| June 30, 2019 | -39.40M |
| March 31, 2019 | 7.60M |
| December 31, 2018 | -40.78M |
| September 30, 2018 | -26.62M |
| June 30, 2018 | -61.12M |
| March 31, 2018 | -55.99M |
| December 31, 2017 | -149.32M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.781M |
| June 30, 2017 | -21.98M |
| March 31, 2017 | -42.29M |
| December 31, 2016 | -97.18M |
| September 30, 2016 | -45.04M |
| June 30, 2016 | -37.24M |
| March 31, 2016 | 1.454M |
| December 31, 2015 | -3.482M |
| September 30, 2015 | -7.24M |
| June 30, 2015 | -0.255M |
| March 31, 2015 | -4.346M |
| December 31, 2014 | -2.633M |
| September 30, 2014 | -3.108M |
| June 30, 2014 | -3.588M |
| March 31, 2014 | -2.157M |
| December 31, 2013 | -2.79M |
| September 30, 2013 | -1.822M |
| June 30, 2013 | -1.626M |
| March 31, 2013 | -1.069M |
| December 31, 2012 | -2.055M |
| September 30, 2012 | -4.687M |
| June 30, 2012 | -2.55M |
| March 31, 2012 | -1.699M |
| December 31, 2011 | -2.276M |
| September 30, 2011 | -3.278M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-88.40M
Minimum
Dec 2022
67.20M
Maximum
Jun 2020
-24.23M
Average
-23.10M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -824.00M |
| Stryker Corp | -408.00M |
| Tandem Diabetes Care Inc | -16.58M |
| Becton Dickinson & Co | -1.056B |
| ResMed Inc | -33.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 45.20M |
| Cash from Financing (Quarterly) | 2.20M |
| Free Cash Flow | 36.50M |
| Free Cash Flow Per Share (Quarterly) | 0.1615 |
| Free Cash Flow to Equity (Quarterly) | 18.20M |
| Free Cash Flow to Firm (Quarterly) | 14.08M |
| Free Cash Flow Yield | 0.28% |